News

It's still a no-go on these items at Chipotle.

By Deena Beasley LOS ANGELES, May 7 (Reuters) - Gilead Sciences on Thursday posted a higher-than-expected first-quarter profit and raised its outlook for 2026 sales, but said it now expects a loss for

(Bloomberg) -- Eli Lilly & Co. sold $9 billion of investment-grade bonds Wednesday — the company’s biggest-ever issuance — as it looks to finance an acquisition spree. Most Read from BloombergUS Has Opened a Passage Through Hormuz, Central Command SaysUS Says Offensive Phase of Iran War Over as Ship Hit in StraitAnthropic Unveils AI Agents to Field Financial Services TasksDOJ Plans Intervention in Trump Supreme Court Carroll AppealTrump Pauses Plan to Guide Ships While Seeking Iran DealThe drugm

(Updates with the company's response in the fourth paragraph.) Eli Lilly (LLY) is looking to rais

Devon reported lower-than-expected first-quarter earnings despite strong oil production and free cash flow generation as the shale producer prepares to close its merger with Coterra Energy.

The billionaire is on the hook for $1.5 million for failing to disclose his 5% stake in Twitter in a timely fashion.

The S&P 500 (^GSPC) opened the week lower as oil prices spiked on renewed Iran tensions, with index futures slipping 0.1% after conflicting reports about a U.S. warship near the Strait of Hormuz. WTI crude futures jumped 3% to trade above $105 per barrel, and Brent climbed 3% to above $111, pulling capital into energy names. Futures recovered once ... S&P 500 Faces Oil-Fueled Sell-off Pressure in Possible Return to Merger Monday Deal

Guggenheim trimmed its price target on Chipotle Mexican Grill (NYSE:CMG) to $35 from $36 on Friday, keeping a Neutral rating as margin pressure forces earnings estimate cuts. Analyst Gregory Francfort lowered both 2026 and 2027 earnings per share (EPS) estimates by about 3%, signaling that profitability headwinds may outlast any near-term traffic recovery. For prudent ... Guggenheim Cuts Chipotle Price Target as Margin Pressure Mounts: Is the Recovery Story Stalling?